Clausenidin from Clausena excavata Burm. causes Apoptosis of Liver Cancer in Mice

Volume 27, Issue 2, February 2026, Pages 481-489

Peter M Waziri; Richard Auta; Mustapha U Imam; Ben A Chindo; Zakari Ladan; Zainab Kasim Mohammed; Samson Wayah; Jaafar Mohammed Sani; Godwin I Ayuba; Oluwafemi T Ige; Daniel Tyoapine; Abel Agbaji

• View Article
• PDF 1.76 M

In Silico Analysis Reveals MDM2 as a Potential Target of Ursolic Acid for Overcoming Tamoxifen Resistance in Breast Cancer

Volume 26, Issue 8, August 2025, Pages 2899-2907

Yohanes Surya Jati; Diyah Novi Sekarini; Nur Ayunie Zulkepli; Dyaningtyas Dewi Pamungkas Putri

• View Article
• PDF 1.06 M

Association of Insertion/Deletion Polymorphisms of MDM2, MCP-1 and VEGF with Esophageal Cancer Risk in North-West Indians: A Case - Control Study

Volume 26, Issue 5, May 2025, Pages 1623-1631

Deepanshi Mahajan; Vasudha Sambyal; Manjit Singh Uppal; Meena Sudan; Kamlesh Guleria

• View Article
• PDF 735.06 K

Alterations in p53 Influence hTERT, VEGF and MMPs Expression in Oral Cancer Patients

Volume 23, Issue 9, September 2022, Pages 3141-3149

Ragini D Singh; Kinjal A Patel; Jayendra B Patel; Prabhudas S Patel

• View Article
• PDF 542.38 K

Association of PIK3CA and MDM2 SNP309 with Cervical Squamous Cell Carcinoma in a Philippine Population

Volume 20, Issue 7, July 2019, Pages 2103-2107

Ourlad Alzeus G Tantengco; Yukiko Nakura; Michinobu Yoshimura; Erlidia F Llamas-Clark; Itaru Yanagihara

• View Article
• PDF 306.69 K

P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy - Iranian Experience

Volume 16, Issue 12, December 2015, Pages 5043-5047

• View Article
• PDF 750.82 K

Role of the MDM2 Promoter Polymorphism (-309T>G) in Acute Myeloid Leukemia Development

Volume 16, Issue 7, July 2015, Pages 2707-2712

• View Article
• PDF 720.79 K

The MDM2 SNP309T>G Polymorphism Increases Bladder Cancer Risk among Caucasians: a Meta-analysis

Volume 15, Issue 13, December 2014, Pages 5277-5281

• View Article
• PDF 1.17 M

Association between the MDM2 T309G Polymorphism and Leukemia Risk: a Meta-analysis

Volume 15, Issue 16, December 2014, Pages 6767-6772

• View Article
• PDF 1.44 M

SCYL1BP1 has Tumor-suppressive Functions in Human Lung Squamous Carcinoma Cells by Regulating Degradation of MDM2

Volume 15, Issue 17, December 2014, Pages 7467-7471

• View Article
• PDF 828.57 K

A Functional SNP in the MDM2 Promoter Mediates E2F1 Affinity to Modulate Cyclin D1 Expression in Tumor Cell Proliferation

Volume 15, Issue 8, August 2014, Pages 3817-3823

• View Article
• PDF 780.01 K

P53 Arg72Pro and MDM2 SNP309 Polymorphisms Cooperate to Increase Lung Adenocarcinoma Risk in Chinese Female Non-smokers: A Case Control Study

Volume 14, Issue 9, September 2013, Pages 5415-5420

• View Article
• PDF 450.07 K

Association Between MDM2 SNP309 T>G and Risk of GastricCancer: A Meta-analysis

Volume 14, Issue 3, March 2013, Pages 1925-1929

• View Article
• PDF 620.44 K

MDM2 T309G has a Synergistic Effect with P21 ser31arg Single Nucleotide Polymorphisms on the Risk of Acute Myeloid Leukemia

Volume 13, Issue 9, September 2012, Pages 4315-4320

• View Article
• PDF 563.76 K

Meta-analysis of Associations between the MDM2-T309G Polymorphism and Prostate Cancer Risk

Volume 13, Issue 9, September 2012, Pages 4327-4330

• View Article
• PDF 366.9 K

Association Between MDM2 Promoter SNP309 T/G Polymorphism and Liver Cancer Risk - a Meta-analysis

Volume 13, Issue 6, June 2012, Pages 2841-2846

• View Article
• PDF 452.77 K